AI-driven discovery and tissue-specific nanoformulation of multi-target small-molecule precision medicines for chronic disorders and cancers. Advancing a clinically validated lead small-molecule candidate to reduce disruptive behaviors in children and adolescents with neurodevelopmental disorders (autism, AD/HD).